COVID-19

COVID-19 in 2025  

The unprecedented COVID-19 pandemic spanning over three years claimed millions of lives worldwide and caused immense misery to the humanity. Rapid developments of vaccines...

CoViNet: A New Network of Global Laboratories for Coronaviruses 

A new global network of laboratories for coronaviruses, CoViNet, has been launched by WHO. The aim behind this initiative is to bring together surveillance...

COVID-19: Severe lung infection affects heart through “cardiac macrophage shift” 

It is known that COVID-19 increases the risk of heart attack, stroke, and Long COVID but what was not known is whether the damage...

The Lambda Variant (C.37) of SARS-CoV2 Has Higher Infectivity and Immune Escape

The Lambda variant (lineage C.37) of SARS-CoV-2 was identified in Southern Brazil. This was found to have high prevalence in some south America. In view...

Another COVID-19 Wave Imminent in France: How Many More Yet to Come?

There has been a rapid increase in the delta variant of SARS CoV-2 in France in June 2021 based on the analysis of 5061 positive...

COVID-19 Outbreak: Bill Introduced in the US Congress to Audit Anthony Fauci’s Emails

A bill H.R.2316 - Fire Fauci Act1 has been introduced into the US Senate to reduce Dr. Anthony Fauci salary along with audit for his correspondence and...

COVID-19 Origin: Poor Bats Can’t Prove Their Innocence

A recent study suggests increased risk of formation of coronavirus hotspots caused due to deforestation and livestock revolution leading to zoonotic transmission of coronavirus...

COVID-19: An Evaluation of Herd Immunity and Vaccine Protection

Herd immunity for COVID-19 is said to be achieved when 67% of the population is immune to the virus through infection and/or vaccination, whilst...

2-Deoxy-D-Glucose(2-DG): A Potentially Suitable anti-COVID-19 drug

2-Deoxy-D-Glucose(2-DG), a glucose analog that inhibits glycolysis, has recently received Emergency Use Authorization (EUA) in India for the treatment of moderate to severe COVID-19 patients....

CD24: an Anti-Inflammatory Agent for Treatment of COVID-19 Patients

The researchers at the Tel-Aviv Sourasky Medical Center have successfully completely Phase I trials for the use of CD24 protein delivered in exosomes to treat COVID-19. Scientists at...

Did the SARS CoV-2 Virus Originate in Laboratory?

There is no clarity on the natural origin of SARS CoV-2 as no intermediate host has been found yet that transmits it from bats...

Stay in touch:

87,351FansLike
41,844FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

Meteor Produces Daytime Bolide and Sonic Boom Across New England  

A loud sonic boom was heard and a fireball seen around 18:06 UTC Saturday 30...

Carbon-free Ferrocene Analog Synthesised

The synthesis of the first carbon-free inorganic sandwich compound  (an osmium...

Outbreak of Bundibugyo Ebolavirus in DR Congo and Uganda

The current orthoebolavirus outbreak in Democratic Republic of Congo...

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...